WALKING DISABILITY side effect
What is WALKING DISABILITY ?WALKING DISABILITY : Lotensin Side Effects Report #5486280-2
Consumer or non-health professional from CHINA reported LOTENSIN problem on Oct 08, 2007. Female patient was treated with LOTENSIN. After drug was administered, patient experienced the following problems/side effects: walking disability, . LOTENSIN dosage: 5 MG, QD. During the same period patient was treated with ISOSORBIDE DINITRATE. Patient recovered.
WALKING DISABILITY : Oxaliplatin Side Effects Report #5624941-2
OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 07, 2008. Female patient was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, walking disability, . OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.
WALKING DISABILITY : Oxaliplatin Side Effects Report #5624945-X
Health Professional from UNITED STATES reported OXALIPLATIN problem on Feb 07, 2008. Female patient was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, walking disability, . OXALIPLATIN dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL. Patient recovered.
WALKING DISABILITY : Nutropin Side Effects Report #5485568-9
NUTROPIN AQ problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2007. Male patient, weighting 29.99 lb, was diagnosed with growth hormone deficiency, body height below normal and was treated with NUTROPIN AQ. After drug was administered, patient experienced the following problems/side effects: speech disorder, walking disability, . NUTROPIN AQ dosage: 0.6 ML, QD. During the same period patient was treated with NUTROPIN AQ, VITAMIN B, VITAMINS NOS. Patient recovered.
WALKING DISABILITY : Nutropin Side Effects Report #5468201-1
Consumer or non-health professional from UNITED STATES reported NUTROPIN AQ problem on Sept 20, 2007. Male patient, weighting 29.99 lb, was diagnosed with growth hormone deficiency, body height below normal and was treated with NUTROPIN AQ. After drug was administered, patient experienced the following problems/side effects: speech disorder, walking disability, . NUTROPIN AQ dosage: 0.6 ML, QD. During the same period patient was treated with NUTROPIN AQ, VITAMIN B, VITAMINS NOS. Patient recovered.
WALKING DISABILITY : Sutent Side Effects Report #5382225-4
SUTENT problem was reported by a Physician from NETHERLANDS on June 27, 2007. Female patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: pain in extremity, walking disability, . SUTENT dosage: unknown. Patient recovered.
WALKING DISABILITY : Lyrica Side Effects Report #5397214-3
Consumer or non-health professional from UNITED STATES reported LYRICA problem on July 13, 2007. Female patient was diagnosed with pain and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, walking disability, . LYRICA dosage: unknown. Patient recovered.
WALKING DISABILITY : Sutent Side Effects Report #5382225-4
SUTENT problem was reported by a Physician from NETHERLANDS on June 27, 2007. Female patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: pain in extremity, walking disability, . SUTENT dosage: unknown. Patient recovered.
WALKING DISABILITY : Lyrica Side Effects Report #5397214-3
Consumer or non-health professional from UNITED STATES reported LYRICA problem on July 13, 2007. Female patient was diagnosed with pain and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, walking disability, . LYRICA dosage: unknown. Patient recovered.
WALKING DISABILITY : Dobupal Side Effects Report #5520557-7
DOBUPAL problem was reported by a Health Professional from SPAIN on Nov 13, 2007. Male patient, 45 years of age, was diagnosed with depression and was treated with DOBUPAL. After drug was administered, patient experienced the following problems/side effects: muscle contractions involuntary, muscle spasms, walking disability, . DOBUPAL dosage: 150 MG PER DAY. Patient recovered.
WALKING DISABILITY : Sutent Side Effects Report #5529635-X
Health Professional from UNITED KINGDOM reported SUTENT problem on Nov 20, 2007. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: hyperkeratosis, palmar-plantar erythrodysaesthesia syndrome, walking disability, . SUTENT dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.